Sign Up to like & get
recommendations!
2
Published in 2021 at "ACS Omega"
DOI: 10.1021/acsomega.1c00772
Abstract: Molnupiravir (MK-4482, EIDD-2801) is a promising orally bioavailable drug candidate for the treatment of COVID-19. Herein, we describe a supply-centered and chromatography-free synthesis of molnupiravir from cytidine, consisting of two steps: a selective enzymatic acylation…
read more here.
Keywords:
molnupiravir 4482;
molnupiravir;
synthesis molnupiravir;
4482 eidd ... See more keywords